CARLOS JAVIER
ANGUITA VELASCO
Profesor asociado de Ciencias de la Salud
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublications en collaboration avec des chercheurs de Hospital General Universitario Gregorio Marañón (50)
2024
-
Digital PCR Improves Sensitivity and Quantification in Monitoring CAR-T Cells in B Cell Lymphoma Patients
Transplantation and Cellular Therapy, Vol. 30, Núm. 3, pp. 306.e1-306.e12
-
Factors related to the development of high antibody titres against SARS-CoV-2 in convalescent plasma donors from the ConPlas-19 trial
Vox Sanguinis, Vol. 119, Núm. 1, pp. 27-33
2023
-
Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide
Annals of Hematology, Vol. 102, Núm. 6, pp. 1561-1567
-
Red Blood Cell Transfusion after Postpartum Hemorrhage: Clinical Variables Associated with Lack of Postpartum Hemorrhage Etiology Identification
Journal of Clinical Medicine, Vol. 12, Núm. 19
-
Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy
Frontiers in immunology, Vol. 14, pp. 1165759
2022
-
Allogeneic CD34-selected stem cell boost as salvage treatment of life-threatening infection and severe cytopenias after CAR-T cell therapy
Transfusion, Vol. 62, Núm. 10, pp. 2143-2147
-
Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation
Frontiers in immunology, Vol. 13, pp. 1002959
-
FLT3-ITD Expression as a Potential Biomarker for the Assessment of Treatment Response in Patients with Acute Myeloid Leukemia
Cancers, Vol. 14, Núm. 16
-
Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility
International Journal of Hematology, Vol. 115, Núm. 1, pp. 61-68
2021
-
Clinical Utility of the Detection of the Loss of the Mismatched HLA in Relapsed Hematological Patients After Haploidentical Stem Cell Transplantation With High-Dose Cyclophosphamide
Frontiers in Immunology, Vol. 12
-
Complete RH and Kell matching related to low alloimmunisation risk in sickle cell disease: prevalence and risk factors of alloimmunisation in a Spanish Tertiary Care National Reference Centre
Blood transfusion = Trasfusione del sangue, Vol. 19, Núm. 4, pp. 292-299
-
Elafin as a Predictive Biomarker of Acute Skin Graft-Versus-Host Disease After Haploidentical Stem Cell Transplantation Using Post-Transplant High-Dose Cyclophosphamide
Frontiers in Immunology, Vol. 12
-
Genetic biomarkers identify a subgroup of high-risk patients within low-risk NPM1-mutated acute myeloid leukemia
Leukemia and Lymphoma, Vol. 62, Núm. 5, pp. 1178-1186
-
International Forum on Transfusion Practices in Haematopoietic Stem-Cell Transplantation: Responses
Vox Sanguinis, Vol. 116, Núm. 5, pp. e25-e43
-
Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant
Frontiers in Immunology, Vol. 12
-
Next generation cytogenetics in myeloid hematological neoplasms: Detection of cnvs and translocations
Cancers, Vol. 13, Núm. 12
-
Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantation
Annals of Hematology, Vol. 100, Núm. 2, pp. 541-553
2020
-
Autologous stem cell transplantation for lymphoma in HIV+ patients: higher rate of infections compared with non-HIV lymphoma
Bone Marrow Transplantation, Vol. 55, Núm. 9, pp. 1716-1725
-
Cytokine release syndrome after allogeneic stem cell transplantation with posttransplant cyclophosphamide
Hematological Oncology, Vol. 38, Núm. 4, pp. 597-603
-
Immunotherapy with CAR-T cells in paediatric haematology-oncology
Anales de Pediatria, Vol. 93, Núm. 1, pp. 59.e1-59.e10